Viral Envelope Proteins - Metabolism
Research News and Information

Monday, November 23, 2009

Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response.

29 Nov 2009 Following our recent findings on the presence of human cytomegalovirus (HCMV) in the normal human adrenal cortex and in adrenocortical tumors, especially in cortisol-secreting tumors, aim of the present study was to investigate the direct effects of ... Read more...

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.

10 Oct 2009 Twenty years after its discovery, HCV (hepatitis C virus) still infects 170 million people worldwide and cannot be properly treated due to the lack of efficient medication. Its life cycle must be better understood to develop targeted pharmacological ... Read more...

Bacterial cell surface display: a method for studying Japanese encephalitis virus pathogenicity.

30 Aug 2009 Infection with Japanese encephalitis virus (JEV), a mosquito-borne, neurotropic flavivirus, may cause acute encephalitis in humans. Recombinant Salmonella typhimurium BRD509 was constructed to display domain III of the envelope (E) protein of JEV ... Read more...

Latest indexed articles for 'Viral Envelope Proteins - Metabolism'

These are the very latest articles for this heading:

• Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response. 29 Nov 2009
• The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership. 10 Oct 2009
• Bacterial cell surface display: a method for studying Japanese encephalitis virus pathogenicity. 30 Aug 2009
• y Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts. 17 Aug 2009
• Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD. 3 Aug 2009
• Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. 3 Aug 2009
• Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. 30 Jul 2009
• Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer. 30 Jul 2009
• A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. 30 Jul 2009
• Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. 26 Jul 2009
• NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. 25 Jul 2009
• Mapping of the functional boundaries and secondary structure of the mouse mammary tumor virus Rem-responsive element. 22 Jul 2009
• A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion. 21 Jul 2009
• Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus. 20 Jul 2009
• Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. 20 Jul 2009
• Membrane proteins follow multiple pathways to the basolateral cell surface in polarized epithelial cells. 18 Jul 2009
• Proviral protein provides placental function. 13 Jul 2009
• Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. 13 Jul 2009
• Structure and inhibition of the SARS coronavirus envelope protein ion channel. 8 Jul 2009
• Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage. 5 Jul 2009

See a longer list of these articles.

Technical information about 'Viral Envelope Proteins'

Definition: Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.

Registry Number: 0

Descriptor UI: D014759

Alternative terms: Viral Envelope Proteins; Proteins, Viral Envelope; Virus Envelope Proteins; Envelope Proteins, Virus; Proteins, Virus Envelope; Envelope Proteins, Viral; Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus); Viral Envelope Proteins gp52; Viral Envelope Proteins gp70; Virus Peplomer Proteins; Peplomer Proteins, Virus; Proteins, Virus Peplomer; Bovine Leukemia Virus Glycoprotein gp51; Corona Virus Membrane Protein E1; Coronavirus gpE1; Coronavirus Peplomer Protein E1; Coronavirus Peplomer Protein E2 JHM; Hepatitis Virus (MHV) Glycoprotein E2; LaCrosse Virus Envelope Glycoprotein G1; Simian Sarcoma Virus Glycoprotein 70; Viral Envelope Glycoprotein gp55 (Friend Virus); Viral Envelope Proteins E1; Viral Envelope Proteins E2;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D12.776.964.970.880;

History Note: 84

Technical Notes: IM; coord with specific virus (IM); /drug eff /ultrastruct permitted